PD-0200347

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-0200347
Drug Alias NameINOS/MMP inhibitor (Pfizer)PD-0200347
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase-1 inhibitorsNitric oxide synthase, inducible inhibitorsMatrix metalloproteinase 13 inhibitors +[4] 
TargetsMatrix metalloproteinase-1Matrix metalloproteinase 13Nitric oxide synthase, inducible +[4] 
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A